Trials / Unknown
UnknownNCT05566340
Treatment of Moderate FMR During AVR
Surgical Treatment of Aortic Valve Disease With Moderate Functional Mitral Regurgitation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 154 (estimated)
- Sponsor
- Fuwai Yunnan Cardiovascular Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Debates exist on the treatment of moderate functional mitral regurgitation (FMR) in patients undergoing aortic valve replacement (AVR) for aortic valve disease. This study aims to evaluate the left ventricular function, which was evaluated through global longitudinal strain, after isolated AVR and AVR + mitral valve repair (MVr) in this group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | mitral valve repair | Repair of mitral valve concomitant to aortic valve replacement. |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-12-01
- First posted
- 2022-10-04
- Last updated
- 2022-10-04
Source: ClinicalTrials.gov record NCT05566340. Inclusion in this directory is not an endorsement.